@FiercePharma: #ICYMI yesterday: $BMY leapfrogs Merck with Opdivo approval in lung cancer. Story | Follow @FiercePharma
@EricPFierce: MS Pharma in Jordan gets $30M development loan to expand its drug manufacturing. News | Follow @EricPFierce
@CarlyHFierce: J&J, Merck to advance #Ebola vaccines in Africa, but their fate rests in WHO's hands. More | Follow @CarlyHFierce
> Actavis ($ACT) lost an intellectual property fight over its osteoporosis med Atelvia, as a U.S. district judge invalidated two key patents; the company says it's reviewing an appeal. Release
> The California Supreme Court heard arguments in a "pay-for-delay" case involving Bayer and its alleged attempts to pay several generics makers to hold off on their copies of the antibiotic Cipro. Report
> Local officials in Hillsborough County, FL, approved $2.1 million in incentives to lure Johnson & Johnson ($JNJ) and 700 new jobs to the area; the county incentives add to $7 million previously approved by the state. Report
> Pharma industry reps told the Irish health committee Oireachtas that drug prices in the country are on par with those in other European countries, amid talks about a new government pricing contract. Report
> A New York federal judge ordered Novartis ($NVS) to hand over unredacted documents by March 13 in a False Claims Act suit over alleged kickbacks to pharmacies. Report
Medical Device News
@FierceMedDev: Micro-cap TearLab gets $35M in debt to get to breakeven on dry eye test. More | Follow @FierceMedDev
@VarunSaxena2: @AdvaMedUpdate calls for more appropriate medical device reimbursement in Japan - FierceMedicalDevices. Story | Follow @VarunSaxena2
@EmilyWFierce: OpGen eyes IPO worth up to $37M for drug-resistant bacteria genetic Dx. FierceDiagnostics article | Follow @EmilyWFierce
> AdvaMed calls for 'more appropriate' medical device reimbursement in Japan. News
> Startup raises $11.7M to make laparoscopic procedures clearer. Item
Biotech News
@FierceBiotech: Biotech upstart Tricida banks $30M for its kidney drug with OrbiMed in tow. Story | Follow @FierceBiotech
@JohnCFierce: Interested in Asian biopharma? Get the latest from @FiercePharmAsia. Newsletter | Follow @JohnCFierce
@DamianFierce: Via @Reuters, it's March 5 and biopharma deal dollars have already topped 2011. Article | Follow @DamianFierce
> Surprised, stunned and supportive: Analysts assess AbbVie's $21B Pharmacyclics deal. Editor's Corner
> Summit pulls off a downsized IPO for its DMD drug. Story
Pharma Asia News
> Major policy shift on costs and safety views as China moves to lift price controls on drugs. News
> Denovo Biopharma eyes China trial of licensed Eli Lilly neuroscience drug. Article
> Indonesia gains momentum as drug firms eye second year of phased national insurance. Item
> Big Pharma bodies ask China FDA to review comparability in biosimilar approval guidelines. More
> Hutchison China MediTech eyes first modern drug approval in China next year with Eli Lilly candidate. Report
Vaccines News
> Pfizer scores new Prevenar indication in Europe. Article
> Bristol-Myers bets $1B on Bavarian Nordic cancer vaccine. News
> J&J, Merck to advance Ebola vaccines in Africa, but their fate rests in WHO's hands. Story
> With 77 layoffs, Valeant gets to work squeezing costs from Dendreon. Item
> Aduro, BMS cancer vaccine combo to start Phase II. Report
Pharma Manufacturing News
> FDA aims to disseminate drug shortage info through app. More
> Generic drugmaker snaps up Lockheed site with big expansion plans. Article
> Jordan's MS Pharma gets $30M to expand manufacturing there. Report
> FDA campaign against use of foreign-made cancer drugs rolls up another doctor. Story
> Patheon buys specialty API maker IRIX. News
And Finally... Anticholinergic drugs, which include commonly used OTC remedies such as Benadryl, might be linked to a higher risk of pneumonia. Report